1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 3: Relations between patients' characteristics and PRU^a
Clinical and Laboratory Variables P PRU
Sex (male) <.001 244 ± 68 vs 291 ± 78
Age (younger than 65 years) .028 268 ± 80 vs 295 ± 72
Body weight (≥60 Kg) .031 267 ± 78 vs 292 ± 76
CPG medication (≥7 days) .003 230 ± 96 vs 283 ± 74
Combination antiplatelet medication (yes) .175 263 ± 83 vs 281 ± 76
Hypertension (no) .745 275 ± 78 vs 278 ± 78
Diabetes mellitus (yes) .184 251 ± 99 vs 279 ± 76
Statin use (no) .198 274 ± 78 vs 293 ± 77
Smoking status (current or past smoker) .071 256 ± 73 vs 282 ± 79
Alcohol intake (yes) .157 260 ± 76 vs 280 ± 78
Hematocrit level (≥38%) .008 263 ± 73 vs 293 ± 81
Platelet count (<227 × 10³/μL) .562 274 ± 80 vs 280 ± 76
Total cholesterol level (<200 mg/dL) .232 273 ± 80 vs 288 ± 71
HDL cholesterol level (≥40 mg/dL) .225 275 ± 79 vs 292 ± 69
LDL cholesterol level (≥130 mg/dL) .608 273 ± 75 vs 280 ± 78
Triglyceride level (<200 mg/dL) .091 274 ± 77 vs 299 ± 72
Procedure-related thromboembolism (no) .061 274 ± 78 vs 318 ± 54

 
a A group of patients denoted within the parentheses showed decreased residual platelet activity.